Mouse Anti-Herpes Simplex Virus (HSV) Type 2 Monoclonal Antibody

Herpes simplex virus type 2 (HSV-2) is a neurotropic virus that primarily causes genital herpes. It is known for its ability to establish lifelong latent infections within the host's nervous system, periodically reactivating to cause recurrent symptoms. The virus's pathogenicity and persistence make it a significant target for antiviral therapies and vaccine development. Key targets for HSV-2 include the viral envelope glycoproteins, such as gD, gB, and gC, which are crucial for viral entry into host cells. These glycoproteins facilitate the attachment and fusion processes, making them prime candidates for neutralizing antibodies and antiviral drugs.